Segment Information (Tables)

12 Months Ended

Dec. 31, 2022

The following tables contain certain financial information by geographic area:


	December 31, 2022
(In millions)	U.S.		Europe(1)		Germany		Asia		Other		Total
Product revenue from external customers	$	3,469.3	$	2,401.3	$	926.2	$	672.1	$	518.9	$	7,987.8
Revenue from anti-CD20 therapeutic programs	1,636.4		0.1		—		—		64.0		1,700.5
Other revenue from external customers	425.8		11.7		—		47.6		—		485.1
Long-lived assets	1,369.4		2,275.8		21.0		13.7		22.6		3,702.5

	December 31, 2021
(In millions)	U.S.		Europe(1)		Germany		Asia		Other		Total
Product revenue from external customers	$	3,805.7	$	2,626.0	$	1,162.4	$	688.0	$	564.8	$	8,846.9
Revenue from anti-CD20 therapeutic programs	1,596.7		—		—		—		61.8		1,658.5
Other revenue from external customers	429.9		9.7		—		36.7		—		476.3
Long-lived assets	1,390.5		2,337.8		25.4		16.4		21.7		3,791.8

	December 31, 2020
(In millions)	U.S.		Europe(1)		Germany		Asia		Other		Total
Product revenue from external customers	$	5,900.1	$	2,495.3	$	1,161.1	$	596.7	$	539.0	$	10,692.2
Revenue from anti-CD20 therapeutic programs	1,897.4		0.1		—		—		80.3		1,977.8
Other revenue from external customers	733.6		8.0		0.1		32.9		—		774.6
Long-lived assets	1,496.3		2,290.2		31.2		16.2		10.9		3,844.8

(1) Represents amounts related to Europe less those attributable to Germany.